New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas

Donzel, Marie; Baseggio, Lucile; Fontaine, Juliette; Pesce, Florian; Ghesquières, Hervé; Bachy, Emmanuel; Verney, Aurélie; Traverse-Glehen, Alexandra

doi:10.3390/curroncol28050297

Open AccessReview

New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas

by

Marie Donzel

¹,

Lucile Baseggio

^2,3,

Juliette Fontaine

¹,

Florian Pesce

¹,

Hervé Ghesquières

^3,4,

Emmanuel Bachy

^3,4,

Aurélie Verney

³ and

Alexandra Traverse-Glehen

^1,3,*

¹

Institut de pathologie multi-sites, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310 Pierre Bénite, France

²

Laboratoire d’hématologie, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310 Pierre Bénite, France

³

INSERM-Unité Mixte de Recherche 1052 CNRS 5286, Team “Clinical and Experimental Models of Lymphomagenesis”, UCBL, Cancer Research Center of Lyon, Université Lyon, 69001 Lyon, France

⁴

Service d’hématologie, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310 Pierre Bénite, France

^*

Author to whom correspondence should be addressed.

Curr. Oncol. 2021, 28(5), 3430-3447; https://doi.org/10.3390/curroncol28050297

Submission received: 13 August 2021 / Revised: 2 September 2021 / Accepted: 3 September 2021 / Published: 6 September 2021

(This article belongs to the Special Issue B Cell Lymphoma in the Spleen)

Download

Browse Figures

Versions Notes

Abstract

Splenic marginal zone lymphoma (SMZL) is a small B-cell lymphoma, which has been recognized as a distinct pathological entity since the WHO 2008 classification. It classically presents an indolent evolution, but a third of patients progress rapidly and require aggressive treatments, such as immuno-chemotherapy or splenectomy, with all associated side effects. In recent years, advances in the comprehension of SMZL physiopathology have multiplied, thanks to the arrival of new devices in the panel of available molecular biology techniques, allowing the discovery of new molecular findings. In the era of targeted therapies, an update of current knowledge is needed to guide future researches, such as those on epigenetic modifications or the microenvironment of these lymphomas.

Keywords: splenic marginal zone lymphoma; review; genetic; molecular

Share and Cite

MDPI and ACS Style

Donzel, M.; Baseggio, L.; Fontaine, J.; Pesce, F.; Ghesquières, H.; Bachy, E.; Verney, A.; Traverse-Glehen, A. New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas. Curr. Oncol. 2021, 28, 3430-3447. https://doi.org/10.3390/curroncol28050297

AMA Style

Donzel M, Baseggio L, Fontaine J, Pesce F, Ghesquières H, Bachy E, Verney A, Traverse-Glehen A. New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas. Current Oncology. 2021; 28(5):3430-3447. https://doi.org/10.3390/curroncol28050297

Chicago/Turabian Style

Donzel, Marie, Lucile Baseggio, Juliette Fontaine, Florian Pesce, Hervé Ghesquières, Emmanuel Bachy, Aurélie Verney, and Alexandra Traverse-Glehen. 2021. "New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas" Current Oncology 28, no. 5: 3430-3447. https://doi.org/10.3390/curroncol28050297

APA Style

Donzel, M., Baseggio, L., Fontaine, J., Pesce, F., Ghesquières, H., Bachy, E., Verney, A., & Traverse-Glehen, A. (2021). New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas. Current Oncology, 28(5), 3430-3447. https://doi.org/10.3390/curroncol28050297

Article Menu

New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI